ロード中...
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...
保存先:
| 出版年: | Brain Behav |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/ https://ncbi.nlm.nih.gov/pubmed/28948074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|